Executives at Quest Diagnostics and Labcorp cheered strong revenue growth in the third quarter. Both companies noted excellent recent launches of Alzheimer’s disease tests. In addition, both companies reported they are leaning heavily into artificial intelligence (AI). Quest and Labcorp touted their entries into Alzheimer’s testing. Quest CEO James Davis said during an investors call, […]
Quest, Labcorp Tout Their Alzheimer’s Tests and Use of AI
National lab companies report robust growth for third quarter as deal-making continues
- By Mark Terry
- > From the Volume XXXII, No. 17 - December 8, 2025 Issue
- Tags: AD-Detect, Adam Schechter, AI, Alzheimer’s disease test, Alzheimer’s-related amyloid pathology, artificial intelligence, biopharma services, blood-based biomarker testing, Christin O’Donnell, Co-Lab, Corewell Health, CrowdStrike, digital pathology, Elevance Health, Fresenius Medical Care, generative AI, genetics testing, Invitae, ivd/lab informatics, James Davis, Julie Wang, LabCorp, LifeLabs, Quest Diagnostics, Sam Samad, Sentara
